Research project:
Radioimmunotherapy with alpha-particle emitting radionuclides.

Education:
The University of Oslo, Faculty of Mathematics and Natural Sciences (1990 - 1997): Master of Science (Cand. Scient) in Biomedical technology. Title of thesis: Light Dosimetry for Photodynamic Therapy.

Kongsberg School of Engineering, Department of Electronics, Technical Cybernetics (1986-1989).

Previous employments:
GE Healthcare AS, Department of Regulatory Affairs (Sept 2005-Aug 2008):
Regulatory Executive, responsible for marketing authorizations of X-ray and MRI contrast media products in dedicated country portfolio and co-ordination of world wide marketing authorizations for new optical imaging product.

GE Healthcare AS (previously Amersham Health AS/Nycomed Imaging AS), Department of Clinical Research (June 2000-Sept 2005):
Clinical Research Associate/Study Monitor responsible for dedicated clinical trials at university hospitals in Norway, Sweden and Denmark. Selection, initiation, monitoring and closure of study centers in international phase 2-4 multi-centre trials according to ICH GCP standards. Applications for Ethics Committees and Health Authorities.

Eli Lilly Norge AS (April 1998-May 2000):
Product Specialist/Sales Representative. Marketing of oncology and osteoporosis prevention products. Sales district: Eastern, southern and northern parts of Norway.

The Norwegian Radium Hospital, Dept. of Surgical Oncology (Jan 1990–March1998):
Sectional engineer/research technician. Assisted in pre-clinical and clinical research projects on radiotherapy and photodynamic therapy. Contributed to several papers and presentations at international conferences.